The clinical relevance of endotoxin in human sepsis: a critical analysis

Abstract

Correlations between circulating endotoxin levels from the blood of septic patients with clinical outcome measures have proven to be rather difficult. The clinical impact of endotoxin in septic patients depends upon the kinetics of LPS release, the concentration of LPS binding proteins, the cellular responsiveness to endotoxin, and numerous other immunogenetic, microbiological and physiological variables. Failure to account for these variables adequately has limited the clinical utility of endotoxin measurement. Several clinical studies have associated high levels of LPS with an excess risk of morbidity and mortality in sepsis that is largely independent of the nature of the micro-organism responsible for the septic episode.

References

Westphal O. , Westphal U. , Sommer T. The history of pyrogen research. In: Schlessinger D. (ed) Microbiol l977. Washington, DC : American Society of Microbiology 1997; 221—238.

Opal SM , Yu Jr RL Antiendotoxin strategies for the prevention and treatment of septic shock new approaches and future directions. Drugs 1998; 55: 497—508.

DaSilva Amt , Kaulbach HC , Chuidian FS , Lambert DR , Suffredini AF , Danner RL Shock and multiple organ dysfunction after self administration of Salmonella endotoxin. N Engl J Med 1993; 328: 1457—1460.

Means TK , Golenbock DT , Fenton MJ The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000; 11: 219—232.

Derkx B. , Wittes J. , McCloskey R. , and the European Pediatric Meningococcal Septic Shock Trial Study Group. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. Clin Infect Dis 1999; 28: 770—777.

Aliprintis AO , Yang RB , Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999; 285: 736—738.

van Deventer Sjm , Buller HR , ten Cate JW , Sturk A. , Paw W. Endotoxemia as an early predictor of septicaemia in febrile patients. Lancet 1988; 1: 605—608.

Bennett-Guerrero E. , Ayuso L. , Hamilton-Davies H. et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 1997; 277: 646—650.

Langevelde PV , Joop K. , Loon JV et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000 ; 31: 1343—1348.

10.

Rauchaus M. , Coats Ajs , Anker SD The endotoxin-lipoprotein hypothesis. Lancet 2000; 356: 930—933.

11.

Levin M. , Qunit PA , Goldstein B. et al. Recombinant bactericidal/ permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 2000; 356: 961—967.

12.

Warren HS , Amato SF , Fitting C. , Black KM , Loiselle PM , Pasternack MS Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 1993; 177: 89—97.

13.

Novitsky TJ Limulus amebocyte lysate (LAL) detection of endotoxinin human blood. J Endotoxin Res 1994 ; 1: 253—263.

14.

Levels Jhm , Abraham PR , van den Ende A. , van Deventer Sjh. Distribution and kinetics of lipoprotein-boundendotoxin. Infect Immun 2001; 69: 2821—2828.

15.

Gordon BR , Parker TS , Levine DM , Saal SD , Wang JC , Sloan BJ Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996 ; 24: 584—589.

16.

Lamping N. , Dettmer R. , Schroder Nwj et al. LPS-binding protein protects mice from septic shock caused by LSP or Gram-negative bacteria. J Clin Invest 1998; 101: 2065—2071.

17.

Gibot S. , Cariou A. , Drouet L. , Rossignol M. , Ripoll L. Association between a genomic polymorphism with the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002; 30: 969—973.

18.

LaVan TD , Bloom JW , Bailey TJ et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167: 5 838-5844.

19.

Lorenz E. , Mira JP , Frees KL , Schwartz DA Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028—1031.

20.

Nomura F. , Akashi S. , Sakao Y. et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000; 164: 3476—3479,

21.

Varma TK , Toliver-Kinsky TE , Lin CY , Koutrouvelis AP , Nichols JE , Sherwood ER Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun 2001; 69: 5249—5263.

22.

Cohen J. TREM-1 in sepsis. Lancet 2001; 358: 776—778.

23.

Gao JJ , Xue Q. , Papasian CJ , Morrison DC Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-aaa through a post-transcriptional mechanism. J Immunol 2001; 166: 6855—6860.

24.

Danner RL , Elin RJ , Hosseini JM Wesley RA , Reilly JM , Parillo JE Endotoxemia in human septic shock. Chest 1991 ; 99: 169—175.

25.

Roger T. , David J. , Glauser MP , Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2002; 414: 920—924.

26.

Echtenacher B. , Freudenberg MA , Jack RS , Mannel DN Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun 2001; 69: 7271—7276.

27.

Opal SM , Scannon PJ , Vincent JL et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 1584—1589.

28.

Hemmi H. , Takeuchi O. , Kawal T. et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740—744.

29.

Hirschfeld M. , Kirschning CJ , Schwandner R. , Wesche H. , Weis JH , Wooten RM Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J Immunol 1999: 163: 2382-2386.

30.

Hayashi F. , Smith KD , Ozinsky A. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099—1103.

31.

Huang Q. , Liu D. , Majewski P. et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001; 294: 870—875.

32.

Pridmore AC , Wyllie DH , Abdillahi F. et al. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183: 89—96.

33.

Casey LC , Balk RA , Bone RC Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771—778.

34.

Levin J. , Poore TE , Young NS et al. Gram-negative sepsis: detection of endotoxemia with the Limulus test: with studies of associated changes in coagulation, serum lipids and complement. Ann Intern Med 1972; 76: 1—7.

35.

Butler J. , Levin J. , Cu DG , Walker RI Bubonic plague: detection of endotoxemia with the Limulus test. Ann Intern Med 1973; 79: 642—646.

36.

Hurley JC Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995; 8: 268—292.

37.

Hurley JC Concordance of endotoxemia with Gram-negative bacteremia: a meta-analysis using receiver operating characteristic curves. Arch Pathol Lab Med 2000; 124: 1157—1164.